Perfil
Paul Schaffer currently works at Telix Pharmaceuticals Ltd., as Chief Technology Officer from 2025.
Dr. Schaffer also formerly worked at Centre For Probe Development & Commercialization, as Director from 2018 to 2021 and ARTMS, Inc., as Chief Technology Officer from 2018 to 2025.
Cargos activos de Paul Schaffer
| Empresas | Cargo | Inicio |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Director Técnico/Científico/I+D | 07/04/2025 |
Antiguos cargos conocidos de Paul Schaffer.
| Empresas | Cargo | Fin |
|---|---|---|
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Director Ejecutivo | 28/03/2018 |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Director/Miembro de la Junta | 17/06/2021 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
- Bolsa de valores
- Insiders
- Paul Schaffer
















